Viewing Study NCT04847466


Ignite Creation Date: 2025-12-24 @ 4:01 PM
Ignite Modification Date: 2025-12-27 @ 9:31 AM
Study NCT ID: NCT04847466
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-24
First Post: 2021-04-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunotherapy Combination: Irradiated PD-L1 CAR-NK Cells Plus Pembrolizumab Plus N-803 for Subjects With Recurrent/Metastatic Gastric or Head and Neck Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module